Cerivastatin

In the US, Cerivastatin (cerivastatin systemic) is a member of the drug class statins and is used to treat High Cholesterol and Hyperlipoproteinemia Type IIa - Elevated LDL.

US matches:

• Cerivastatin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AA06

CAS registry number (Chemical Abstracts Service)

0145599-86-6

Chemical Formula

C26-H34-F-N-O5

Molecular Weight

459

Therapeutic Category

Antilipemic agent, HMG CoA reductase inhibitor (statin)

Chemical Name

6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-[S-[R*,S*-(E)]]-

Foreign Names

• Cerivastatinum (Latin)
• Cerivastatin (German)
• Cérivastatine (French)
• Cerivastatina (Spanish)

Generic Names

• Cerivastatin (OS: BAN)
• Cérivastatine (OS: DCF)
• Cerivastatin Sodium (OS: BANM, USAN)
• Bay W 6228 (IS: Bayer)

Brand Names

• Lipobay
  Bayer, United Arab Emirates; Bayer, Bahrain; Bayer, Cyprus; Bayer, Egypt; Bayer, Iran; Bayer, Jordan; Bayer, Kenya; Bayer, Kuwait; Bayer, Lebanon; Bayer, Qatar; Bayer, Saudi Arabia; Bayer, Sudan; Bayer, Tanzania; Bayer, Uganda; Bayer Yakuhin, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.